(Total Views: 728)
Posted On: 05/14/2020 3:23:42 PM
Post# of 155801
https://finance.yahoo.com/news/japan-says-dru...15022.html
Interesting statement
"A trial performed by the U.S. Institutes of Health (NIH) showed remdesivir drug cut hospital stays by 31% compared with a placebo treatment, although it did not significantly improve survival"
Did not improve survival, thats a shame. I wish it did improve survival but it doesn't, Leronlimab does significantly improve survival. Its a shame it hasn't yet been approved for comp use as of yet.
Interesting statement
"A trial performed by the U.S. Institutes of Health (NIH) showed remdesivir drug cut hospital stays by 31% compared with a placebo treatment, although it did not significantly improve survival"
Did not improve survival, thats a shame. I wish it did improve survival but it doesn't, Leronlimab does significantly improve survival. Its a shame it hasn't yet been approved for comp use as of yet.
(2)
(0)
